venBio Select Advisor as of March 31, 2018
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 52 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 11.6 | $248M | 17M | 14.61 | |
| Amicus Therapeutics (FOLD) | 8.3 | $178M | 12M | 15.04 | |
| BioMarin Pharmaceutical (BMRN) | 7.1 | $152M | 1.9M | 81.07 | |
| Iovance Biotherapeutics (IOVA) | 6.4 | $137M | 8.1M | 16.90 | |
| Mirati Therapeutics | 6.3 | $135M | 4.4M | 30.70 | |
| Ascendis Pharma A S (ASND) | 6.3 | $135M | 2.1M | 65.40 | |
| Global Blood Therapeutics In | 4.3 | $93M | 1.9M | 48.30 | |
| Avexis | 3.9 | $83M | 675k | 123.58 | |
| Tg Therapeutics (TGTX) | 3.5 | $74M | 5.2M | 14.20 | |
| Horizon Pharma | 3.4 | $73M | 5.2M | 14.20 | |
| Argenx Se (ARGX) | 3.2 | $69M | 863k | 80.44 | |
| Clovis Oncology | 2.9 | $62M | 1.2M | 52.80 | |
| Puma Biotechnology (PBYI) | 2.6 | $56M | 825k | 68.05 | |
| Medicines Company | 2.5 | $54M | 1.6M | 32.94 | |
| Assembly Biosciences | 2.5 | $54M | 1.1M | 49.14 | |
| Pacira Pharmaceuticals (PCRX) | 2.5 | $53M | 1.7M | 31.15 | |
| Endocyte | 2.4 | $52M | 5.7M | 9.09 | |
| Zogenix | 2.2 | $48M | 1.2M | 40.05 | |
| Vanda Pharmaceuticals (VNDA) | 2.2 | $47M | 2.8M | 16.85 | |
| Armo Biosciences Ord | 2.1 | $45M | 1.2M | 37.41 | |
| Dynavax Technologies (DVAX) | 1.5 | $33M | 1.7M | 19.85 | |
| Array BioPharma | 1.5 | $31M | 1.9M | 16.32 | |
| Dermira | 1.3 | $27M | 3.4M | 7.99 | |
| Catalyst Biosciences | 1.2 | $26M | 1.0M | 25.80 | |
| AstraZeneca (AZN) | 1.2 | $26M | 750k | 34.97 | |
| Teligent | 0.8 | $18M | 5.3M | 3.36 | |
| Intec Pharma | 0.7 | $14M | 2.2M | 6.35 | |
| BioDelivery Sciences International | 0.6 | $12M | 5.4M | 2.25 | |
| Jounce Therapeutics | 0.6 | $12M | 523k | 22.35 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.5 | $11M | 4.7M | 2.39 | |
| AVEO Pharmaceuticals | 0.4 | $9.4M | 3.2M | 2.90 | |
| D Stemline Therapeutics | 0.4 | $8.0M | 524k | 15.30 | |
| Karyopharm Therapeutics (KPTI) | 0.3 | $7.5M | 561k | 13.42 | |
| Oncosec Med | 0.3 | $7.5M | 4.0M | 1.88 | |
| Apellis Pharmaceuticals (APLS) | 0.3 | $7.5M | 397k | 18.79 | |
| Alimera Sciences | 0.3 | $6.4M | 6.2M | 1.03 | |
| Viveve Med | 0.3 | $5.6M | 1.5M | 3.66 | |
| Viewray (VRAYQ) | 0.2 | $4.0M | 730k | 5.54 | |
| Tandem Diabetes Care (TNDM) | 0.2 | $3.9M | 784k | 4.96 | |
| Agenus (AGEN) | 0.2 | $3.3M | 705k | 4.71 | |
| Dova Pharmaceuticals | 0.2 | $3.4M | 125k | 27.12 | |
| Fennec Pharmaceuticals (FENC) | 0.1 | $3.3M | 273k | 12.04 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.1 | $2.8M | 6.0M | 0.46 | |
| Solid Biosciences | 0.1 | $2.1M | 275k | 7.50 | |
| Uniqure Nv (QURE) | 0.1 | $1.6M | 68k | 23.50 | |
| SPDR S&P Biotech (XBI) | 0.1 | $998k | 750k | 1.33 | |
| ACADIA Pharmaceuticals (ACAD) | 0.0 | $597k | 817k | 0.73 | |
| Veracyte (VCYT) | 0.0 | $665k | 120k | 5.56 | |
| Oncobiologics | 0.0 | $608k | 684k | 0.89 | |
| Macrogenics (MGNX) | 0.0 | $79k | 15k | 5.44 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $4.7k | 233k | 0.02 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $12k | 233k | 0.05 |
